ClinicalTrials HQ

Department of Psychiatry, China Medical University Hospital

Department of Psychiatry, China Medical University Hospital

Taichung, Taiwan

11 results ยท Page 1 of 1

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Dual Modulation of Sigma-1 and NMDA Receptors in the Treatment of SchizophreniaSchizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophreniaRecruitingPhase 22026-03-24NCT06574360
Combination of NMDA-enhancing and Anti-inflammatory Treatments for Ultra-resistant SchizophreniaInflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophreniaRecruitingPhase 22026-03-24NCT05240976
Early Intervention of Prodromal Schizophrenia Using an NMDA EnhancerPersonality Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophrenia, schizotypal personality disorderRecruitingPhase 22026-03-24NCT05052853
Monotherapy of an NMDA Enhancer for SchizophreniaSchizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophreniaRecruitingPhase 22026-03-24NCT04745143
Sex Differences in NMDA-enhancing Treatment of SchizophreniaSchizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophreniaRecruitingPhase 22025-09-17NCT07122895
NMDA-enhancing Treatment for Cognitive Dysfunction of SchizophreniaSchizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophreniaRecruitingPhase 22025-02-19NCT06021197
NMDA Receptor Modulation for the Treatment of Bipolar I DisorderBipolar and Related Disorders, bipolar I disorder, bipolar disorder, mood disorder, psychiatric disorderRecruitingPhase 22025-02-19NCT05977023
NMDA Modulation in Antidepressant Nonresponders With Major Depressive Disorderdepressive disorder, major depressive disorder, mood disorder, psychiatric disorderRecruitingPhase 22025-02-19NCT05136755
Combination of NMDA-enhancing and Antioxidant Treatments for SchizophreniaSchizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophreniaRecruitingPhase 22025-02-19NCT04959201
Combination of NMDA-enhancing and Anti-inflammatory Treatments for SchizophreniaInflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizophreniaRecruitingPhase 22025-02-19NCT04917302
NMDA Modulation in Major Depressive Disorderdepressive disorder, major depressive disorder, mood disorder, psychiatric disorderRecruitingPhase 22025-02-19NCT04637620